DERMAPHARM HOLDING SE (DMP.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:DMP - DE000A2GS5D8 - Common Stock
37 EUR
-0.25 (-0.67%)
DMP gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 53 industry peers in the Pharmaceuticals industry. DMP has only an average score on both its financial health and profitability. DMP is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year DMP was profitable.
In the past year DMP had a positive cash flow from operations.
Each year in the past 5 years DMP has been profitable.
DMP had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
DMP has a Return On Assets (5.48%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 17.87%, DMP is in the better half of the industry, outperforming 62.26% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 7.26%, DMP is in line with its industry, outperforming 47.17% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for DMP is below the industry average of 13.94%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.48% | ||
| ROE | 17.87% | ||
| ROIC | 7.26% |
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
1.3 Margins
The Profit Margin of DMP (10.00%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of DMP has declined.
DMP has a Operating Margin of 18.70%. This is comparable to the rest of the industry: DMP outperforms 50.94% of its industry peers.
In the last couple of years the Operating Margin of DMP has grown nicely.
DMP has a Gross Margin (66.57%) which is comparable to the rest of the industry.
DMP's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.7% | ||
| PM (TTM) | 10% | ||
| GM | 66.57% |
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DMP is creating some value.
DMP has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for DMP remains at a similar level compared to 5 years ago.
The debt/assets ratio for DMP is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.23 indicates that DMP is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.23, DMP is in line with its industry, outperforming 43.40% of the companies in the same industry.
The Debt to FCF ratio of DMP is 6.15, which is on the high side as it means it would take DMP, 6.15 years of fcf income to pay off all of its debts.
DMP has a Debt to FCF ratio of 6.15. This is comparable to the rest of the industry: DMP outperforms 45.28% of its industry peers.
A Debt/Equity ratio of 1.44 is on the high side and indicates that DMP has dependencies on debt financing.
With a Debt to Equity ratio value of 1.44, DMP is not doing good in the industry: 75.47% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.44 | ||
| Debt/FCF | 6.15 | ||
| Altman-Z | 2.23 |
ROIC/WACC1.09
WACC6.66%
2.3 Liquidity
A Current Ratio of 2.20 indicates that DMP has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.20, DMP is in the better half of the industry, outperforming 73.58% of the companies in the same industry.
A Quick Ratio of 1.04 indicates that DMP should not have too much problems paying its short term obligations.
The Quick ratio of DMP (1.04) is better than 66.04% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.2 | ||
| Quick Ratio | 1.04 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 28.01% over the past year.
The Earnings Per Share has been growing by 8.07% on average over the past years. This is quite good.
DMP shows a small growth in Revenue. In the last year, the Revenue has grown by 0.11%.
DMP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.00% yearly.
EPS 1Y (TTM)28.01%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%26.56%
Revenue 1Y (TTM)0.11%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%-5.36%
3.2 Future
The Earnings Per Share is expected to grow by 14.68% on average over the next years. This is quite good.
DMP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.09% yearly.
EPS Next Y12.59%
EPS Next 2Y11.78%
EPS Next 3Y11.05%
EPS Next 5Y14.68%
Revenue Next Year-0.83%
Revenue Next 2Y1.53%
Revenue Next 3Y2.28%
Revenue Next 5Y3.09%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 17.21, the valuation of DMP can be described as rather expensive.
Based on the Price/Earnings ratio, DMP is valued a bit cheaper than the industry average as 62.26% of the companies are valued more expensively.
DMP's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.38.
DMP is valuated correctly with a Price/Forward Earnings ratio of 14.48.
69.81% of the companies in the same industry are more expensive than DMP, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.83, DMP is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.21 | ||
| Fwd PE | 14.48 |
4.2 Price Multiples
77.36% of the companies in the same industry are more expensive than DMP, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DMP indicates a rather cheap valuation: DMP is cheaper than 84.91% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.12 | ||
| EV/EBITDA | 9.42 |
4.3 Compensation for Growth
DMP's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.37
PEG (5Y)2.13
EPS Next 2Y11.78%
EPS Next 3Y11.05%
5. Dividend
5.1 Amount
DMP has a Yearly Dividend Yield of 2.42%. Purely for dividend investing, there may be better candidates out there.
DMP's Dividend Yield is a higher than the industry average which is at 1.85.
Compared to an average S&P500 Dividend Yield of 1.87, DMP pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.42% |
5.2 History
The dividend of DMP has a limited annual growth rate of 2.71%.
Dividend Growth(5Y)2.71%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
41.76% of the earnings are spent on dividend by DMP. This is a bit on the high side, but may be sustainable.
The dividend of DMP is growing, but earnings are growing more, so the dividend growth is sustainable.
DP41.76%
EPS Next 2Y11.78%
EPS Next 3Y11.05%
FRA:DMP (12/19/2025, 7:00:00 PM)
37
-0.25 (-0.67%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners11.86%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.99B
Revenue(TTM)1.16B
Net Income(TTM)116.03M
Analysts78.18
Price Target42.84 (15.78%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.42% |
Yearly Dividend0.88
Dividend Growth(5Y)2.71%
DP41.76%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.94%
PT rev (3m)-0.94%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.36%
EPS NY rev (3m)-1.01%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.25%
Revenue NY rev (3m)-0.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.21 | ||
| Fwd PE | 14.48 | ||
| P/S | 1.72 | ||
| P/FCF | 12.12 | ||
| P/OCF | 9.65 | ||
| P/B | 3.07 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.42 |
EPS(TTM)2.15
EY5.81%
EPS(NY)2.56
Fwd EY6.91%
FCF(TTM)3.05
FCFY8.25%
OCF(TTM)3.84
OCFY10.37%
SpS21.55
BVpS12.06
TBVpS-7.73
PEG (NY)1.37
PEG (5Y)2.13
Graham Number24.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.48% | ||
| ROE | 17.87% | ||
| ROCE | 11.89% | ||
| ROIC | 7.26% | ||
| ROICexc | 7.91% | ||
| ROICexgc | 21.74% | ||
| OM | 18.7% | ||
| PM (TTM) | 10% | ||
| GM | 66.57% | ||
| FCFM | 14.17% |
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
ROICexc(3y)10.97%
ROICexc(5y)11.73%
ROICexgc(3y)29.64%
ROICexgc(5y)29.05%
ROCE(3y)16.03%
ROCE(5y)16.96%
ROICexgc growth 3Y-9.69%
ROICexgc growth 5Y2.94%
ROICexc growth 3Y-20.13%
ROICexc growth 5Y-1%
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
F-Score7
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.44 | ||
| Debt/FCF | 6.15 | ||
| Debt/EBITDA | 3.09 | ||
| Cap/Depr | 49.31% | ||
| Cap/Sales | 3.63% | ||
| Interest Coverage | 4.01 | ||
| Cash Conversion | 68.3% | ||
| Profit Quality | 141.71% | ||
| Current Ratio | 2.2 | ||
| Quick Ratio | 1.04 | ||
| Altman-Z | 2.23 |
F-Score7
WACC6.66%
ROIC/WACC1.09
Cap/Depr(3y)41.99%
Cap/Depr(5y)70.86%
Cap/Sales(3y)3.57%
Cap/Sales(5y)4.47%
Profit Quality(3y)204.39%
Profit Quality(5y)161.92%
High Growth Momentum
Growth
EPS 1Y (TTM)28.01%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%26.56%
EPS Next Y12.59%
EPS Next 2Y11.78%
EPS Next 3Y11.05%
EPS Next 5Y14.68%
Revenue 1Y (TTM)0.11%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%-5.36%
Revenue Next Year-0.83%
Revenue Next 2Y1.53%
Revenue Next 3Y2.28%
Revenue Next 5Y3.09%
EBIT growth 1Y5.29%
EBIT growth 3Y-8.31%
EBIT growth 5Y13.3%
EBIT Next Year57.06%
EBIT Next 3Y20.08%
EBIT Next 5Y7.73%
FCF growth 1Y-31.18%
FCF growth 3Y-4.81%
FCF growth 5Y24.67%
OCF growth 1Y-25.65%
OCF growth 3Y-7%
OCF growth 5Y14.89%
DERMAPHARM HOLDING SE / DMP.DE FAQ
What is the fundamental rating for DMP stock?
ChartMill assigns a fundamental rating of 5 / 10 to DMP.DE.
What is the valuation status for DMP stock?
ChartMill assigns a valuation rating of 5 / 10 to DERMAPHARM HOLDING SE (DMP.DE). This can be considered as Fairly Valued.
How profitable is DERMAPHARM HOLDING SE (DMP.DE) stock?
DERMAPHARM HOLDING SE (DMP.DE) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for DMP stock?
The Price/Earnings (PE) ratio for DERMAPHARM HOLDING SE (DMP.DE) is 17.21 and the Price/Book (PB) ratio is 3.07.
What is the earnings growth outlook for DERMAPHARM HOLDING SE?
The Earnings per Share (EPS) of DERMAPHARM HOLDING SE (DMP.DE) is expected to grow by 12.59% in the next year.